LineaRx to Support Therapy Development for Neurodegenerative Diseases
June 26th, 2019
Tag: Large-scale DNA production
LineaRx Anticipates Expansion in Diagnostics Market
May 21st, 2019
LineaRx Achieves Higher Expression and Survival Rates in Human T Cells
April 29th, 2019
Linear DNA Crosses the Line between Tags and Therapeutics
April 9th, 2019
LineaRx Achieves Anti-CD19 Expression in Human CAR T Cells via Plasmid-Free Platform
April 8th, 2019
LineaRx Provides Cost and Quality Advantages to Technogenetics
November 7th, 2018
Applied DNA Subsidiary LineaRx Licenses CAR T Drug Candidate and Initiates Pre-Clinical Development of Non-viral, Plasmid-free CAR T Manufacturing Platform
October 16th, 2018
LineaRx Secures New RNA Therapeutics Customers for Contract Research Services
October 1st, 2018
LineaRx agreement with Takis and Evvivax for cancer vaccines
September 21st, 2018